Ajay Sinha

Dr. Ajay Sinha

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
ASAjay Sinha
Ajay Sinha
ASAnja Saso
Anja Saso
AMArikana Mufunde
Arikana Mufunde
SKSteven T. Kempley
Steven T. Kempley
MWMark Wilks
Mark Wilks
MMMike Millar
Mike Millar
Objective: The study aimed to assess the relationship between clinical features, routine laboratory parameters, including conventional blood culture, and identification of microorganisms by a commercial system of Polymerase Chain Reaction coupled with Electrospray Ionization Mass Spectrometry (PCR/ESI-MS) (Abbot Iridica) in infants with suspected early-onset infection.Study design: Prospective observational cohort study.Setting: Neonatal intensive care unit and postnatal ward at a tertiary hospital within an urban setting.Patients: Neonates >=34 weeks gestation with clinically suspected early-onset infection between January 2016 and March 2017 were recruited. Blood samples were taken at the time of suspected infection for both blood culture inoculation (BacT/ALERT® system) and PCR/ESI-MS analysis (0.5ml). An electronic database was used to document demographic and clinical details.Results: 54 infants were studied with a median (IQR) gestational age and birth weight of 39.7 (37.5-41.0) weeks and 3.2 (2.7-3.5) kg respectively. 1 infant had both bacterial DNA detected on PCR/ESI-MS and bacterial growth on blood culture (Group B Streptococcus). 9 infants had bacterial DNA detected but with negative blood culture. The bacteria identified were Streptococcus sp (n=3) Sneathia (n=1), Cutibacterium acnes(n=6),. All infants with no bacterial DNA detected on PCR/ESI-MS also had a negative blood culture result. Infants with positive bacterial DNA identification in blood had significantly higher CRP values; initially (p=0.002), when repeated after 18-24 hours (p=0.02) and maximally within the first 72 hours (p=0.03). The proportion of infants with a CRP> 5 mg/L was significantly higher if bacterial DNA had been detected (p=0.01).Conclusions: PCR/ESI-MS detected bacterial DNA of organisms considered pathogenic in four times more blood samples than culture alone, and had a high sensitivity and negative predictive value. Bacterial DNA was detected by PCR/ESI-MS in infants who did not have bacterial growth on blood culture and this was associated with a raised inflammatory marker. It may be a useful tool to exclude sepsis in the neonatal cohort and reassess the need for prolonged antibiotic treatment. The results are promising but there is a need to improve blood collection methods to take advantage of the potential benefits of molecular detection.